MedTrace Logo

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

NCT05522465 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 608

Last updated 2024-05-16

No results posted yet for this study

Summary

Comparison of the efficacy and safety of short-course high-dose prednisone and dexamethasone in the treatment of children with newly diagnosed immune thrombocytopenia (ITP)

Conditions

Interventions

DRUG

Prednisone

Prednisone 4mg/kg.d, d1-4

DRUG

Dexamethasone

Dexamethasone 0.6mg/kg.d, d1-4

Sponsors & Collaborators

  • The First Affiliated Hospital of Xiamen University

    collaborator OTHER

  • Zhangzhou Affiliated Hospital of Fujian Medical University

    collaborator OTHER

  • Quanzhou First Hospital

    collaborator OTHER

  • Nanping First Hospital Affiliated to Fujian Medical University

    collaborator UNKNOWN

  • The Second Hospital of Anhui Medical University

    collaborator OTHER

  • The Affiliated Hospital Of Guizhou Medical University

    collaborator OTHER

  • Longyan City First Hospital

    collaborator OTHER

  • The Affiliated Hospital of Putian University

    collaborator OTHER

  • Fujian Medical University Union Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
29 Days
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-11
Primary Completion
2025-08-31
Completion
2026-08-31

Countries

  • China

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05522465 on ClinicalTrials.gov